Connexin 26 is a protein that builds tiny passageways between cells deep in the inner ear, and changes in the gene that makes it are the single most common cause of hearing loss that is inherited and present before a child learns to speak.1PubMed Central. Hearing loss and connexin 26. Most affected children are born to parents who hear normally, because the gene has to be changed on both copies before hearing is affected.2PubMed Central. Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss The problem sits in the inner ear’s support system rather than in the hearing nerve, which is part of why cochlear implant results tend to be good.
How Connexin 26 Keeps the Inner Ear Working
Your lab report may name the gene GJB2, which holds the instructions for making connexin 26. Six connexin 26 units link into a ring, and two rings from neighboring cells join to form a channel straight from one cell into the next.3PubMed. Structure of the connexin 26 gap junction channel at 3.5 A resolution Cells joined this way can pass small particles, such as salts, directly to each other.
A result listing a GJB2 change means those building instructions carry a spelling difference, and the protein made from them may be shortened, misshapen, or missing. The protein is made in the support cells that surround the hair cells, not in the hair cells themselves, so the faulty part of the ear is the scaffolding around the sound sensors. The outer and middle ear stay normal, so this is an inner-ear hearing loss. The result names where the problem lies, but it does not say how much hearing a child has. Hearing tests answer that.
The cochlea is the snail-shaped hearing organ of the inner ear, lined with sensory hair cells that turn sound vibrations into nerve signals. Each time sound moves the hair cells, potassium flows into them from the fluid around them.4PubMed. Potassium ion recycling pathway via gap junction systems in the mammalian cochlea and its interruption in hereditary nonsyndromic deafness The potassium is then released into surrounding support cells and passed along through connexin channels, so it can be returned to the fluid and used again.5PubMed. Potassium ion recycling pathway via gap junction systems in the mammalian cochlea and its interruption in hereditary nonsyndromic deafness This recycling keeps up the electrical charge in the ear’s fluid that hair cells need to work, and losing connexin function lowers that charge.6PubMed Central. A deafness mechanism of digenic Cx26 (GJB2) and Cx30 (GJB6) mutations: Reduction of endocochlear potential by impairment of heterogeneous gap junctional function in the cochlear lateral wall The hair cells may start out healthy but cannot keep working without the support network around them.
Connexin 26 is used in other tissues too, but the ear depends on it heavily. Other connexins can fill in for it in many tissues, though not well in the cochlea. So most affected children have hearing loss alone, with no other health problems.
In mice lacking connexin 26 in the ear, the sound-sensing tissue starts breaking down within the first month and is gone throughout the cochlea by six months.7PubMed Central. Connexin 26 null mice exhibit spiral ganglion degeneration that can be blocked by BDNF gene therapy The tissue does not fail all at once; it deteriorates over weeks to months, so damage can be underway before or soon after birth. In humans, lost hair cells do not grow back, so the loss is permanent. Hearing aids can only help while some hair cells remain, and an implant, which bypasses them, becomes the route for profound loss. In one examined human inner ear with connexin 26 hearing loss, nearly all hair cells were gone but the hearing nerve cells were well preserved.8PubMed. Temporal bone histopathology in connexin 26-related hearing loss
How Hearing Parents Pass On Connexin 26 Hearing Loss
Most connexin 26 hearing loss is recessive, meaning a person needs a changed copy from each parent to be affected.9PubMed Central. Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss A carrier, someone with one changed copy and one working copy, usually hears normally. When two carriers have a child, each pregnancy has a 1 in 4 chance of hearing loss, a 1 in 2 chance of a hearing carrier, and a 1 in 4 chance of neither. In one family, both parents heard normally and carried one changed copy, while their only child had severe hearing loss from infancy.10PubMed Central. Screening of Connexin 26 in Nonsyndromic Hearing Loss Carriers can pass the change down for many generations without anyone being affected, and hearing loss appears only when two carriers happen to have children together.
The 1 in 4 figure applies fresh to every pregnancy, like a roll of the dice, so having one child with hearing loss does not make the next three unaffected. Having a hearing child first does not change the odds for a later child either. A hearing child of two carriers has a 2 in 3 chance of being a carrier, which is worth knowing when that child grows up and plans a family. If the parents carry different changes, the same 1 in 4 logic still applies.
Carriers are common. Up to about 4 in 100 people of European ancestry carry a changed copy.11PubMed Central. Hearing loss and connexin 26. Most of these carry the same change, called 35delG, a single missing letter in the gene; your report may list it by that name.12PubMed Central. Hearing loss and connexin 26. This change traces back to one ancient ancestor, whose descendants spread it widely.13PubMed Central. A common founder for the 35delG GJB2 gene mutation in connexin 26 hearing impairment The most common changes differ by ancestry, though, and some groups carry other versions more often.14PubMed. Carrier frequency of GJB2 gene mutations c.35delG, c.235delC and c.167delT among the populations of Eurasia
Brothers and sisters of a carrier each have a 1 in 2 chance of being carriers themselves. A relative who is a carrier is not at risk of hearing loss from it, so testing is about family planning rather than their own health. A relative’s partner would also need to be a carrier for a child to be affected, and carrier testing for the partner is possible.
There are less common patterns. Sometimes one changed connexin 26 copy combines with a large missing piece of the neighboring gene for connexin 30 to cause hearing loss.15PubMed. A deletion involving the connexin 30 gene in nonsyndromic hearing impairment If a deaf child shows only one changed copy, doctors may look for a second change, including that connexin 30 deletion. Standard tests may miss it, so a one-copy result may be incomplete rather than ruling the gene out. It is worth asking the genetics team whether the full gene and the connexin 30 region were checked.
A few specific connexin 26 changes cause hearing loss with only one copy, passed directly from an affected parent.16Human Mutation. Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins These changed proteins interfere with the working copy’s proteins rather than just being absent.17PubMed Central. A novel dominant GJB2 (DFNA3) mutation in a Chinese family
How Severe It Is and Whether It Gets Worse
Hearing loss is usually most severe when both copies have changes that cut the protein short, and mildest when both have smaller changes that leave it mostly intact.18PubMed. Connexin-26-associated deafness: phenotypic variability and progression of hearing loss Even with the same changes, the degree and timing of hearing loss can’t be reliably predicted for an individual child.19PubMed Central. Screening of Connexin 26 in Nonsyndromic Hearing Loss Two children with identical changes can hear differently, even within one family. Other genes and unknown factors seem to shape how the ear copes without connexin 26. A child’s own hearing tests therefore count for more than the gene result when deciding what support is needed, and no one should assume a younger sibling will have the same degree of loss as an older child.
Day to day, the loss affects both ears and is usually present before speech develops. It comes from the inner ear rather than from wax or fluid. Mild loss may show up as missed soft sounds or quiet speech rather than total silence.
About 24 in 100 children with connexin 26 hearing loss lost more hearing on repeated tests, rising to about 28 in 100 counting children who passed their newborn screen but later lost hearing.20PubMed. Connexin-26-associated deafness: phenotypic variability and progression of hearing loss So passing the newborn hearing screen does not rule out connexin 26 hearing loss. A change called p.V37I, more common in people of East Asian ancestry, often causes mild hearing loss that worsens slowly.21PubMed. Connexin-26-associated deafness: phenotypic variability and progression of hearing loss
Audiologists retest at intervals through childhood to catch any change early, and hearing aids may be adjusted as results change. At home, a child with progressing loss may begin turning up the television, asking for repeats, or missing quiet speech they used to follow. In a baby or toddler, fewer responses to quiet sounds or a change in babbling or early speech can be signs worth reporting. Ear infections can add a temporary loss on top of connexin 26 loss, so a retest also checks for a fixable problem. Report these changes to the audiologist rather than waiting for the next scheduled appointment.
Cochlear Implants and Hearing Aids
A cochlear implant is a surgically placed device that skips the damaged hair cells and stimulates the hearing nerve directly. Profoundly deaf people with connexin 26 hearing loss can hear and understand speech well with an implant.22PubMed Central. Performance of Cochlear Implant Recipients With GJB2-Related Deafness Their hearing and speech scores match those of other implant users, both soon after surgery and years later.23PubMed. Predictive factors and outcomes of cochlear implantation in patients with connexin 26 mutation: a comparative study Children with connexin 26 changes did slightly better on long-term speech tests than other implanted children.24PubMed. Long term speech perception after cochlear implant in pediatric patients with GJB2 mutations The likely reason is that the hearing nerve often survives.
Knowing the cause helps with the decision. Connexin 26 hearing loss rarely comes with brain or nerve problems that limit implant results, and in one comparison the exact gene change did not predict results, though implanting early is generally linked to better language outcomes.
Getting an implant involves several steps. Before surgery the team checks the child’s ears and does imaging to confirm the inner ear and hearing nerve are suitable. The operation places an electrode array in the cochlea and a receiver under the skin behind the ear, typically under general anesthesia. Hearing begins only weeks later, when the external processor is switched on and programmed, in a separate visit. After that come repeated adjustments and therapy sessions, because the brain needs time to learn to interpret the signal.
Children with mild or moderate loss usually start with hearing aids, which amplify sound for the remaining hair cells. Aids make sound louder, so they help only when enough working hair cells remain to use it. Because connexin 26 loss can progress, a child’s aids often need reprogramming as hearing tests change. The practical measure is whether the child can hear the full range of speech sounds with the aids on, and an audiologist can check this. If speech is still out of reach with well-fitted aids worn consistently, that is the time to ask about an implant evaluation.
Devices are not the only path. Many families also use sign language, and some deaf families prefer it to implants. Early intervention services support language whichever path is chosen, and choosing a communication approach is a family decision, not a medical requirement.
Connexin 26 Changes That Also Affect the Skin
Connexin 26 is also used in the skin, so a few specific changes cause thickened skin along with hearing loss.25PubMed Central. Connexins and the Epithelial Tissue Barrier: A Focus on Connexin 26 One, Vohwinkel syndrome, causes thick skin on palms and soles and tight bands around fingers or toes that can cut off a digit.26PubMed Central. Connexins and the Epithelial Tissue Barrier: A Focus on Connexin 26 Another, KID syndrome, causes scaly, inflamed skin, eye surface problems, and deafness.27PubMed Central. Connexins and the Epithelial Tissue Barrier: A Focus on Connexin 26 Both are rare compared with hearing loss alone, and they come from different changes than the common ones.
The skin syndromes come from changes that alter the protein’s behavior in a harmful way, so one changed copy is enough to cause them. The common 35delG change instead removes the protein, which the skin can usually manage with other connexins, so the skin stays normal. That is why the same gene can cause deafness alone in one family and skin disease with deafness in another. It helps to ask the genetics team to name the exact change and say whether it is linked to skin problems.
Thickened skin on the palms or soles, tight bands on the digits, or scaly red patches in a child with hearing loss are reasons to see a dermatologist. Such signs, together with the exact gene change, help the care team decide whether a skin syndrome is involved. These syndromes usually come from a parent with the same change or a new change in the child, so family history of skin problems is worth sharing.
Genetic Testing and Planning Future Children
Some places add genetic screening to the newborn hearing check, using a few drops of blood from the baby’s heel taken in the first days of life.28PubMed Central. Concurrent newborn hearing and genetic screening of common hearing loss variants with bloodspot-based targeted next generation sequencing in Jiangxi province It can identify babies with mild or later-starting hearing loss that the hearing screen alone misses.29Genetics in Medicine. Newborn genetic screening for hearing impairment: a population-based longitudinal study Full genetic testing for deafness, though, can take weeks to months, and results can be hard to interpret.30PubMed Central. A proposal for comprehensive newborn hearing screening to improve identification of deaf and hard-of-hearing children A carrier result on a newborn screen means one changed copy was found, which usually goes with normal hearing, though a second change may have been missed, so the hearing results still matter.
The two kinds of test answer different questions. A newborn hearing screen measures the baby’s response to sound, while a genetic test reads the gene. A baby who fails the screen is usually sent for a diagnostic hearing evaluation, and a genetic test is often added to look for a cause. The gene test gives a cause but not the degree of hearing loss, so the audiology results still guide care.
Once a child’s changes are known, parents and siblings can be tested to see who carries them. Carrier couples can test embryos made through IVF so that only unaffected ones are transferred.31PubMed. Reproductive management through integration of PGD and MPS-based noninvasive prenatal screening/diagnosis for a family with GJB2-associated hearing impairment That involves the cost and demands of fertility treatment. Tests during pregnancy can check the baby’s genes, including from a sample of the mother’s blood.32PubMed. Reproductive management through integration of PGD and MPS-based noninvasive prenatal screening/diagnosis for a family with GJB2-associated hearing impairment Other procedures take a sample from the placenta or the fluid around the baby, and some carry a small risk of miscarriage, which is worth raising with the counselor. Couples can also choose no testing and have hearing tests and support ready for the baby.
A genetic counselor is the person to meet before a next pregnancy. Useful questions: which exact changes were found and whether they are linked to progression, whether the connexin 30 deletion was tested, and whether siblings should have hearing and gene checks.
Screening brings worries too. Results can cause anxiety before any hearing loss appears, and families have the right to decide what testing they want.
Is Gene Therapy for Connexin 26 Coming
Researchers use harmless modified viruses to deliver working copies of a gene into the inner ear.33PubMed Central. Combined AAV-mediated specific Gjb2 expression restores hearing in DFNB1 mouse models It is placed into the inner ear fluid, where it enters cells, and the cells begin to make the missing protein. Delivering connexin 26 this way rebuilt the cell-to-cell channel network in mice lacking it.34Gene Therapy. Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice A combined approach restored hearing in mice with the condition.35PubMed Central. Combined AAV-mediated specific Gjb2 expression restores hearing in DFNB1 mouse models
Aim matters. Putting connexin 26 into the wrong ear cells damaged hearing, so treatments must target only support cells.36PubMed Central. Combined AAV-mediated specific Gjb2 expression restores hearing in DFNB1 mouse models Different virus types reach different cell types, which is why choosing one that reaches support cells counts. The cochlea is also small and sits deep in the skull, so reaching it safely in a human baby is a technical challenge.
Timing may matter too, since the inner ear’s response depended on its stage of development in mice.37PubMed Central. GJB2 gene therapy and conditional deletion reveal developmental stage-dependent effects on inner ear structure and function The right window in a human child is not known. Hair cells already lost cannot be restored by adding a gene.
Mouse results do not mean a human treatment is ready, and the timing is unknown. Waiting for gene therapy is not a reason to delay hearing aids, implants, or language support, and because ear damage begins early, early access to sound matters now.